English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Objective: To evaluate the clinical effects of radiofrequency ablation (RFA) for transarterial chemoembolization (TACE) postoperative residual tumor in liver cancer. Methods: A retrospective analysis was performed involving patients with a diagnosis of primary liver cancer who received interventional therapy in the Invasive Technology Department of the Third Affiliated Hospital of Wenzhou Medical University from January 1, 2010 to January 1, 2013. The patients receiving only TACE treatment (43 cases) comprised the TACE group, and patients who received TACE and RFA combined treatment (31 cases) made up the combined treatment group. A comparative analysis assessing therapeutic effect, progression-free survival (PFS), overall survival (OS) and adverse reactions was conducted between the two

Therapeutic Effect Analysis of Radiofrequency Ablation on Transarterial Chemoembolization Postoperative Residual